Medical and Pharmaceutical Aerosols - Aerosols: Measurement, Dosimetry, and Health Effects - page 24

78. Hickey, A.J., Martonen, T.B., and Yang, Y. Theoretical relationship of lung deposition to the ine particle
fraction of inhalation aerosols. Pharmaceutica Acta Helvetiae 71 , 185-190 (1996).
79. Hickey, A.J., Concessio, N.M., Van Oort, M.M., and Platz, R.M. Factors inluencing the dispersion of dry
powders as aerosols. Pharmaceutical Technology 18 , 58-58 (1994).
80. Calvert, G., Ghadiri, M., and Tweedie, R. Aerodynamic dispersion of cohesive powders: A review of
understanding and technology. Advanced Powder Technology 20 , 4-16 (2009).
81. Lucas, P., Anderson, K., Potter, U.J., and Staniforth, J.N. Enhancement of small particle size dry pow-
der aerosol formulations using an ultra low density additive. Pharmaceutical Research 16 , 1643-1647
(1999).
82. Lucas, P., Anderson, K., and Staniforth, J.N. Protein deposition from dry powder inhalers: Fine particle
multiplets as performance modiiers. Pharmaceutical Research 15 , 562-569 (1998).
83. Musante, C.J. et al. Factors affecting the deposition of inhaled porous drug particles. Journal of
Pharmaceutical Sciences 91 , 1580-1590 (2002).
84. Joshi, M. and Misra, A. Liposomal budesonide for dry powder inhaler: Preparation and stabilization.
AAPS PharmSciTech 02 , e25 (2001).
85. Bi, R. and Zhang, N. Liposomes as a carrier for pulmonary delivery of peptides and proteins. Journal of
Biomedical Nanotechnology 3 , 332-341 (2007).
86. Lu, D. and Hickey, A.J. Liposomal dry powders as aerosols for pulmonary delivery of proteins. AAPS
PharmSciTech 6 , E641-E648 (2005).
87. Crowder, T. and Hickey, A. Powder speciic active dispersion for generation of pharmaceutical aerosols.
International Journal of Pharmaceutics 327 , 65-72 (2006).
88. Newman, S.P. and Busse, W.W. Evolution of dry powder inhaler design, formulation, and performance.
Respiratory Medicine 96 , 293-304 (2002).
89. Son, Y. and McConville, J.T. Advancements in dry powder delivery to the lung. Drug Development and
Industrial Pharmacy 34 , 948-959 (2008).
90. Peart, J. and Clarke, M.J. New developments in dry powder inhaler technology. American Pharmaceutical
Review 14 , 37-45 (2001).
91. Smith, S.J. and Bernstein, J.A. Therapeutic uses of lung aerosols. Inhalation Aerosols: Physical and
Biological Basis for Therapy 94 , 233-269 (1996).
92. Taburet, A. and Schmit, B. Pharmacokinetic optimisation of asthma treatment. Clinical Pharmacokinetics
26 , 396-418 (1994).
93. Ilowite, J. Techniques of aerosol therapy. Emergency Medicine 23(7), 68-76 (1991).
94. Denyer, J. et al. Evaluation of the target inhalation mode (TIM) breathing maneuver in simulated nebu-
lizer therapy in patients with cystic ibrosis. Journal of Aerosol Medicine and Pulmonary Drug Delivery
23 , S29-S36 (2010).
95. Nikander, K., Prince, I., Coughlin, S., Warren, S., and Taylor, G. Mode of breathing-tidal or slow and
deep-through the I-neb adaptive aerosol delivery (AAD) system affects lung deposition of Tc-99 m-DTPA.
Journal of Aerosol Medicine and Pulmonary Drug Delivery 23 , S37-S43 (2010).
96. Hardaker, L. and Hatley, R. In vitro characterization of the I-neb adaptive aerosol delivery (AAD) sys-
tem. Journal of Aerosol Medicine and Pulmonary Drug Delivery 23 , S11-S20 (2010).
97. Niven, R.W. Delivery of biotherapeutics by inhalation aerosol. Critical Reviews in Therapeutic Drug
Carrier Systems 12 , 151-231 (1995).
98. Newnham, D.M. and Lipworth, B.J. Nebuliser performance, pharmacokinetics, airways and systemic effects
of salbutamol given via a novel nebuliser delivery system (“Ventstream”). Thorax 49 , 762-770 (1994).
99. Baker, P. and Stimpson, P. Electronically controlled drug delivery systems based on the piezoelectric
crystal. In: Byron, P., Dalby, R.N., and Farr, S.J., eds. Proceedings of Respiratory Drug Delivery IV .
Interpharm Press: Buffalo Grove, IL, pp. 273-285 (1994).
100. Dalby, R.N., Tiano, S.L., and Hickey, A.J. Medical devices for the delivery of therapeutic aerosols to the
lungs. Inhalation Aerosols: Physical and Biological Basis for Therapy 94 , 441-473 (1996).
101. Boucher, R.M. and Kreuter, J. The fundamentals of the ultrasonic atomization of medicated solutions.
Annals of Allergy 26 , 591-600 (1968).
102. Niven, R.W. Atomization and nebulizers. In: Hickey, A.J., ed. Inhalation Aerosols: Physical and
Biological Basis for Therapy . Marcel Dekker, Inc.: New York, pp. 273-312 (1996).
103. Greenspan, B.J. Ultrasonic and electrohydrodynamic methods for aerosol generation. Inhalation
Aerosols: Physical and Biological Basis for Therapy 94 , 313-335 (1996).
104. Johnson, J., Waldrep, J., Guo, J., and Dhand, R. Aerosol delivery of recombinant human DNase I: In
vitro comparison of a vibrating-mesh nebulizer with a jet nebulizer. Respiratory Care 53 , 1703-1708
(2008).